Silo Pharma Inc. (SILO) saw downtrend of -5.45% in the recent trading with $1.91 being its most recent. The current price level -84.65% lower than the highest price of $12.44 marked by the stock while trading over the past 52-weeks, whereas it is -3.54% higher than the lowest price of $1.98 the company dropped to over past 52-weeks. The latest news story on SILO appeared in GlobeNewswire under the title “Silo Pharma Announces Positive Results from IND-Enabling Study of SP-26 for Fibromyalgia” on Mar-15-23.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Squeezing the time span to 30 day period shows us the stock is currently trading -30.55% below one month high and is +9.76% above of the lowest during that time. Looking into the simple moving average, Silo Pharma Inc. (SILO)’s stock stands at a SMA-50 of $2.55 while that of 5-day is reading $2.09.
Daily rise and fall of price influence many of the traders, and in order to overcome the fluctuating effect of that and to watch the stock closely, traders focus more on stock’s 200-day moving average. At various points in trading activity, investors are more likely to be making use of that measure as a strong indicator in figuring out their support and resistance levels, and SILO’s SMA-200 as of now is $4.83.
Silo Pharma Inc. Earnings – What Happened With SILO
Coming around sales and income figures on SILO Stock Income Statement, public trading companies under normal circumstances post earnings and revenues near to average estimates by the Wall Street analysts, but those could came either above or below estimates and known as surprise factor. During the reported three-month period, company’s sales were $18.0 million.
SILO – Silo Pharma Inc. Stock Earnings Estimates
Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 3.14 million. SILO does have institutional investors; and they hold 1.60% of the stock.
Silo Pharma Inc. – Insider Activity and Holdings
Moreover, the latest SEC filings also revealed that stock came across 2 new insider purchases involving 330 shares. On the other hand, SILO declared 0 shares have been sold in 0 insider transactions over the past three months.
The liquidity is a key characteristic of any stock and is the main point of focus of both short-term as well as long term investors before start trading into a stock. In recently reported quarter, current ratio recorded by Silo Pharma Inc. was 21.23 while posting a debt to equity ratio of 0.00.
Technical Analysis of Silo Pharma Inc. (NASDAQ:SILO) stock
To comprehend better with the trade moves and investors’ behavior, exploring the short, medium and long term technical indicators along with average volume of a stock is an effective way to make use of. When looking into those indicators for Silo Pharma Inc. (SILO), we notice that the stock’s 20-day average volume is at 120,380 shares and 100% of short term indicators are suggesting the stock as Sell. Medium term indicators at an average of 100% are spotting the stock at Sell with its 50-day average volume of 291,776 shares. And to end, SILO’s 100-day average volume is 412,970 shares with 100% of the long-term indicators pointing towards Sell for the stock.